MDR is the European Union regulation that sets requirements for placing medical devices on the EU market, including classification, technical documentation, and post-market surveillance. It replaced the Medical Devices Directive and imposes broader obligations on economic operators; in translation and localization, it drives updates to labels, instructions for use, declarations of conformity, and vigilance content across EU languages for each member state.
MDR appears in EU market-access projects where manufacturers update technical files, labels, IFUs, and post-market surveillance documents. Translators work with notified-body feedback and language variants for each member state, often aligning terminology across multiple official languages while preserving regulatory intent, usability requirements, and consistency with the source technical documentation from the manufacturer.
A common mistake is treating MDR as a single document that only affects labels; it also changes technical documentation, clinical evidence, and post-market obligations. Translators sometimes retain legacy directive terminology or country-specific wording that conflicts with current requirements, creating inconsistencies that notified bodies may flag during review of the technical file.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →